ACM
ELGX

Archon Capital Management’s Endologix Inc ELGX Stock Holding History

Archon Capital Management’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-215,162
Closed -$1.56M – 31
2019
Q2 		$1.56M Buy
+215,162
New +$1.47M 0.29% 27

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Archon Capital Management's ELGX Position: Q3 2019 in Review

Archon Capital Management sold out of Endologix Inc (ELGX) in Q3 2019, closing a stake of 215,162 shares — an estimated $1.56M sold.

Archon Capital Management first reported a position in ELGX in Q2 2019 and held it in 1 quarter. The position peaked at $1.56M in Q2 2019. 63 funds tracked by Wall St. Rank hold ELGX as of Q3 2019.

  • Archon Capital Management reported no remaining Endologix Inc position as of Q3 2019 after selling out during the quarter.
  • Archon Capital Management sold 215,162 Endologix Inc shares in Q3 2019, an estimated $1.56M.
  • Archon Capital Management first reported a position in Endologix Inc in Q2 2019 and held it in 1 quarter.
  • Archon Capital Management's Endologix Inc position peaked at $1.56M in Q2 2019.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2019.

Based on Archon Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.